4331-29-7

Basic information

• Product Name: 1H-BENZIMIDAZOL-7-AMINE
• Synonyms: 4-AMINOBENZIMIDAZOLE;7-AMINOBENZIMIDAZOLE;1H-Benzimidazol-4-amine;4-Amino-1H-benzimidazole;1H-benzo[d]imidazol-4-amine;1H-1,3-benzodiazol-7-aMine;1H-benzimidazol-7-amine hydrochloride;1H-benzo[d]imidazol-7-amine hydrochloride
• CAS NO: 4331-29-7
• Molecular Formula: C₇H₇N₃
• Molecular Weight: 133.15058
• Product Categories: BENZIMIDAZOLE;pharmacetical;Imidazol&Benzimidazole
• Mol File: 4331-29-7.mol
• Article Data: 14

Chemical Properties

• Melting Point: 120-121 °C
• Boiling Point: 476.07 °C at 760 mmHg
• Flash Point: 273.167 °C
• Appearance: /
• Density: 1.367 g/cm³
• Vapor Pressure: 3.15E-09mmHg at 25°C
• Refractive Index: 1.78
• Storage Temp.: 2-8°C(protect from light)
• PKA: 13.60±0.30(Predicted)
• CAS DataBase Reference: 1H-BENZIMIDAZOL-7-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-BENZIMIDAZOL-7-AMINE(4331-29-7)
• EPA Substance Registry System: 1H-BENZIMIDAZOL-7-AMINE(4331-29-7)

Safety Data

• Hazardous Substances Data: 4331-29-7(Hazardous Substances Data)

Usage

Safety Profile

Mutation data reported. Whenheated to decomposition it emits toxic vapors of NOx.

InChI:InChI=1/C7H7N3/c8-5-2-1-3-6-7(5)10-4-9-6/h1-4H,8H2,(H,9,10)

Upstream product

• 64-18-6 formic acid 
• 66046-54-6 1,2,3-triaminobenzene dihydrochloride 
• 606-22-4 2,6-dinitroaniline 
• 137654-47-8 4(7)-formylbenzimidazole 
• 3694-52-8 2,3-diamino-nitrobenzene 
• 10597-52-1 4-nitro-benzimidazole 

Downstream Products

• 855526-29-3 N⁶-benzoyl-1,3-dideazaadenine 
• 20649-47-2 1,3-Dideazaadenosine 
• 1333332-16-3 3-(benzyloxy)-1-[1-(2-chlorobenzyl)-1H-benzimidazol-4-yl]pyridin-4(1H)-one 
• 1333331-93-3 1-(1H-benzimidazol-4-yl)-5-hydroxy-2-methylpyridin-4(1H)-one 
• 1333331-92-2 1-(1H-benzimidazol-4-yl)-5-(benzyloxy)-2-methylpyridin-4(1H)-one 
• 1333331-61-5 1-[1-(2-chloro-6-fluorobenzyl)-1H-benzimidazol-4-yl]-5-hydroxy-2-methylpyridin-4(1H)-one 
• 1348215-89-3 7-(3-biphenyl-4-yl-5-ethyl-4H-1,2,4-triazol-4-yl)-1H-benzimidazole 
• 1380314-50-0 C₁₇H₁₉N₃O₂S 
• 902131-51-5 4-[3-(4-bromobenzyl)ureido]benzoimidazol-1-carboxylic acid methyl ester 
• 902131-29-7 4-amino-1H-benzimidazole-1-carboxylic acid methyl ester 
• 650638-11-2 (3H-benzoimidazol-4-yl)-hydrazine 
• 369652-68-6 2-[1⁽³⁾H-benzimidazol-4-ylamino]-3-nitrobenzoic acid 

Relevant articles and documents

Investigating chelating sulfonamides and their use in metalloproteinase inhibitors

Matrix metalloproteinase inhibitors (MMPi) utilize zinc-binding groups (ZBGs) to chelate the catalytic Zn(ii) ion resulting in enzyme inhibition. Adapting findings from the literature of Zn(ii) ion sensors, we previously reported chelating sulfonamide inh

INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS

The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved

Compositions for dyeing keratinous fiber

A composition for dyeing keratinous fiber which includes incorporated therein an oxidative color-developing substance, an enzyme which reacts with oxygen as a substrate but does not evolve hydrogen peroxide, and a weak reducing agent.